These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19019193)

  • 1. Severe HDL deficiency due to novel defects in the ABCA1 transporter.
    Pisciotta L; Bocchi L; Candini C; Sallo R; Zanotti I; Fasano T; Chakrapani A; Bates T; Bonardi R; Cantafora A; Ball S; Watts G; Bernini F; Calandra S; Bertolini S
    J Intern Med; 2009 Mar; 265(3):359-72. PubMed ID: 19019193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two novel missense mutations in ABCA1 result in altered trafficking and cause severe autosomal recessive HDL deficiency.
    Albrecht C; Baynes K; Sardini A; Schepelmann S; Eden ER; Davies SW; Higgins CF; Feher MD; Owen JS; Soutar AK
    Biochim Biophys Acta; 2004 May; 1689(1):47-57. PubMed ID: 15158913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and functional analyses of novel mutations of ATP-binding cassette transporter-1 in Japanese patients with high-density lipoprotein deficiency.
    Nishida Y; Hirano K; Tsukamoto K; Nagano M; Ikegami C; Roomp K; Ishihara M; Sakane N; Zhang Z; Tsujii Ki K; Matsuyama A; Ohama T; Matsuura F; Ishigami M; Sakai N; Hiraoka H; Hattori H; Wellington C; Yoshida Y; Misugi S; Hayden MR; Egashira T; Yamashita S; Matsuzawa Y
    Biochem Biophys Res Commun; 2002 Jan; 290(2):713-21. PubMed ID: 11785958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of novel loss of function mutations in ATP-binding cassette transporter A1 in patients with low plasma high-density lipoprotein cholesterol.
    Candini C; Schimmel AW; Peter J; Bochem AE; Holleboom AG; Vergeer M; Dullaart RP; Dallinga-Thie GM; Hovingh GK; Khoo KL; Fasano T; Bocchi L; Calandra S; Kuivenhoven JA; Motazacker MM
    Atherosclerosis; 2010 Dec; 213(2):492-8. PubMed ID: 20880529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tangier disease caused by compound heterozygosity for ABCA1 mutations R282X and Y1532C.
    Cameron J; Ranheim T; Halvorsen B; Kulseth MA; Leren TP; Berge KE
    Atherosclerosis; 2010 Mar; 209(1):163-6. PubMed ID: 19765707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency.
    Fasano T; Zanoni P; Rabacchi C; Pisciotta L; Favari E; Adorni MP; Deegan PB; Park A; Hlaing T; Feher MD; Jones B; Uzak AS; Kardas F; Dardis A; Sechi A; Bembi B; Minuz P; Bertolini S; Bernini F; Calandra S
    Mol Genet Metab; 2012 Nov; 107(3):534-41. PubMed ID: 22959828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations.
    Mott S; Yu L; Marcil M; Boucher B; Rondeau C; Genest J
    Atherosclerosis; 2000 Oct; 152(2):457-68. PubMed ID: 10998475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional mutations of the ABCA1 gene in subjects of French-Canadian descent with HDL deficiency.
    Alrasadi K; Ruel IL; Marcil M; Genest J
    Atherosclerosis; 2006 Oct; 188(2):281-91. PubMed ID: 16343503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCA1-dependent mobilization of lysosomal cholesterol requires functional Niemann-Pick C2 but not Niemann-Pick C1 protein.
    Boadu E; Nelson RC; Francis GA
    Biochim Biophys Acta; 2012 Mar; 1821(3):396-404. PubMed ID: 22179027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel polypyrimidine variation (IVS46: del T -39...-46) in ABCA1 causes exon skipping and contributes to HDL cholesterol deficiency in a family with premature coronary disease.
    Hong SH; Rhyne J; Miller M
    Circ Res; 2003 Nov; 93(10):1006-12. PubMed ID: 14576201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common and rare ABCA1 variants affecting plasma HDL cholesterol.
    Wang J; Burnett JR; Near S; Young K; Zinman B; Hanley AJ; Connelly PW; Harris SB; Hegele RA
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1983-9. PubMed ID: 10938021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for functional sequence variations and mutations in ABCA1.
    Probst MC; Thumann H; Aslanidis C; Langmann T; Buechler C; Patsch W; Baralle FE; Dallinga-Thie GM; Geisel J; Keller C; Menys VC; Schmitz G
    Atherosclerosis; 2004 Aug; 175(2):269-79. PubMed ID: 15262183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction abolishment between mutant caveolin-1(Δ62-100) and ABCA1 reduces HDL-mediated cellular cholesterol efflux.
    Kuo CY; Lin YC; Yang JJ; Yang VC
    Biochem Biophys Res Commun; 2011 Oct; 414(2):337-43. PubMed ID: 21951852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel missense mutation of ABCA1 in transmembrane alpha-helix in a Japanese patient with Tangier disease.
    Maekawa M; Kikuchi J; Kotani K; Nagao K; Odgerel T; Ueda K; Kawano M; Furukawa Y; Sakurabayashi I
    Atherosclerosis; 2009 Sep; 206(1):216-22. PubMed ID: 19344898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders.
    Pisciotta L; Hamilton-Craig I; Tarugi P; Bellocchio A; Fasano T; Alessandrini P; Bon GB; Siepi D; Mannarino E; Cattin L; Averna M; Cefalù AB; Cantafora A; Calandra S; Bertolini S
    Atherosclerosis; 2004 Feb; 172(2):309-20. PubMed ID: 15019541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of antioxidant/anti-inflammatory properties and apoA-I-containing subpopulations of HDL from family subjects with monogenic low HDL disorders.
    Daniil G; Phedonos AA; Holleboom AG; Motazacker MM; Argyri L; Kuivenhoven JA; Chroni A
    Clin Chim Acta; 2011 Jun; 412(13-14):1213-20. PubMed ID: 21420943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin-induced decrease in ATP-binding cassette transporter A1 expression via microRNA33 induction may counteract cholesterol efflux to high-density lipoprotein.
    Niesor EJ; Schwartz GG; Perez A; Stauffer A; Durrwell A; Bucklar-Suchankova G; Benghozi R; Abt M; Kallend D
    Cardiovasc Drugs Ther; 2015 Feb; 29(1):7-14. PubMed ID: 25749868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasomal inhibition promotes ATP-binding cassette transporter A1 (ABCA1) and ABCG1 expression and cholesterol efflux from macrophages in vitro and in vivo.
    Ogura M; Ayaori M; Terao Y; Hisada T; Iizuka M; Takiguchi S; Uto-Kondo H; Yakushiji E; Nakaya K; Sasaki M; Komatsu T; Ozasa H; Ohsuzu F; Ikewaki K
    Arterioscler Thromb Vasc Biol; 2011 Sep; 31(9):1980-7. PubMed ID: 21817095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional rescue of mutant ABCA1 proteins by sodium 4-phenylbutyrate.
    Sorrenson B; Suetani RJ; Williams MJ; Bickley VM; George PM; Jones GT; McCormick SP
    J Lipid Res; 2013 Jan; 54(1):55-62. PubMed ID: 23087442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
    Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
    Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.